Latest filing published 29 Apr 2020 for Arrowhead Pharmaceuticals, INC., €959.
Filing timeline
BuySaleInsider track record
Bruce D. Given: trading record in brief
Bruce D. Given is a declared insider at 2 companies; the most frequent names are Arrowhead Pharmaceuticals, Inc. and Encysive Pharmaceuticals Inc. Over a trading history stretching from 2 March 2006 to 28 April 2020, the count stands at 63 filings.
The open-market record consists of 34 sales worth €12.5M, with no purchase. The rest of the record consists of 11 share grants and 18 option exercises. In 2020 alone, the filings show no purchases and 18 sales.
The newest entry dates from 29 April 2020: an option exercise of €959, in Arrowhead Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Bruce D. Given
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 200 shares@ US$5.190.0% of flowCommon StockSEC:0001209191-20-026230:0
- 200 shares@ US$40.000.2% of flowCommon StockSEC:0001209191-20-026230:1
- 100 shares@ US$40.000.1% of flowCommon StockSEC:0001209191-20-026230:2
- 500 shares@ US$7.750.1% of flowCommon StockSEC:0001209191-20-026230:3
- 1,454 shares@ US$14.540.6% of flowCommon StockSEC:0001209191-20-026230:4
- 1,200 shares@ US$4.750.2% of flowCommon StockSEC:0001209191-20-026230:5
- 830 shares@ US$5.190.1% of flowCommon StockSEC:0001209191-20-026230:6
- 213 shares@ US$5.200.0% of flowCommon StockSEC:0001209191-20-026230:7
- 500 shares@ US$40.000.6% of flowCommon StockSEC:0001209191-20-026230:8
- 1,454 shares@ US$40.001.7% of flowCommon StockSEC:0001209191-20-026230:9
- 1,200 shares@ US$40.001.4% of flowCommon StockSEC:0001209191-20-026230:10
- 830 shares@ US$40.001.0% of flowCommon StockSEC:0001209191-20-026230:11
- 213 shares@ US$40.000.3% of flowCommon StockSEC:0001209191-20-026230:12
- 204 shares@ US$40.000.2% of flowCommon StockSEC:0001209191-20-026230:13
- 700 shares@ US$40.000.8% of flowCommon StockSEC:0001209191-20-026230:14
- 3,800 shares@ US$4.750.5% of flowCommon StockSEC:0001209191-20-025382:0
- 3,700 shares@ US$5.190.6% of flowCommon StockSEC:0001209191-20-025382:1
- 3,456 shares@ US$5.200.5% of flowCommon StockSEC:0001209191-20-025382:2
- 5,300 shares@ US$14.542.3% of flowCommon StockSEC:0001209191-20-025382:3
- 3,800 shares@ US$40.004.5% of flowCommon StockSEC:0001209191-20-025382:4
- 3,700 shares@ US$40.004.3% of flowCommon StockSEC:0001209191-20-025382:5
- 3,456 shares@ US$40.004.1% of flowCommon StockSEC:0001209191-20-025382:6
- 5,300 shares@ US$40.006.2% of flowCommon StockSEC:0001209191-20-025382:7
- 3,454 shares@ US$40.004.1% of flowCommon StockSEC:0001209191-20-025382:8
- 3,805 shares@ US$40.004.5% of flowCommon StockSEC:0001209191-20-025382:9
25 of 63 declarations
